Press Release   -

Anti-snoring Devices And Snoring Surgery Market Poised for Expansion as Demand for Non-Invasive Sleep Solutions Surges Worldwide

The global anti-snoring devices and snoring surgery Market is gaining momentum as healthcare systems, sleep-medicine clinics, and device manufacturers respond to increasing prevalence of snoring and related sleep-disordered breathing (SDB). According to a report from Vantage Market Research, the market was valued at USD 0.91 billion in 2024 and is projected to reach USD 2.58 billion by 2035, demonstrating a compound annual growth rate (CAGR) of approximately 9.95% over the 2025-2035 period. This press release presents key take-aways, detailed market summary including size and trends, segmentation insights (by device type, surgical procedure, and end-use), regional trends, company insights, recent developments, the scope of the report and an overview of market dynamics including drivers, restraints, opportunities and challenges.

Key Takeaways

1. The market for both anti-snoring devices and snoring surgery is expected to nearly triple in value from 2024 to 2035, reflecting strong growth potential.
2. Growth is being driven by increased awareness of the health impacts of snoring and obstructive sleep apnea (OSA), higher rates of obesity and ageing populations, and a shift towards minimally invasive surgical interventions.
3. Device innovations (oral appliances, nasal devices, EPAP, tongue stabilising devices) and surgical advancements (radiofrequency ablation, laser-assisted procedures) are supporting adoption across both clinical and home-care settings.
4. The market remains somewhat concentrated in developed regions (especially North America) but with fastest growth expected in Asia Pacific, offering significant geographic opportunity.
5. Leading companies are forming strategic partnerships, launching improved device offerings, and expanding into emerging markets, underscoring a maturing but still dynamic competitive landscape.

Key Market Trends & Insights

The landscape of anti-snoring treatment is broadening beyond basic positional aids and CPAP machines. Non-invasive oral appliances such as mandibular advancement devices (MADs) and tongue-retaining/stabilising devices are gaining preference due to ease of use. Meanwhile, surgical procedures for snoring and mild OSA such as radiofrequency ablation (RFA), laser-assisted uvulopalatoplasty (LAUP), uvulopalatopharyngoplasty (UPPP) are evolving to offer reduced recovery times and improved patient comfort. Tele-health, home-sleep testing, and wearable monitoring devices are also enabling earlier intervention. Moreover, rising prevalence of obesity, smoking, alcohol consumption and ageing populations are elevating demand. According to Vantage Market Research, the oral appliance segment dominated among devices due to its non-invasive nature and among surgical procedures, RFA is expected to lead due to its minimal side effects and faster recovery.

Market Size & Forecast

1. 2024 Revenue: USD 0.91 billion.
2. 2035 Forecast: USD 2.58 billion.
3. CAGR (2025-2035): 9.95%.

The anti-snoring devices and snoring surgery market displays moderate concentration: a handful of device manufacturers and surgical equipment/therapy providers dominate major geographies, while smaller niche players focus on specific categories like home-use appliances or minimally invasive surgical kits. Characteristics include:

1. A hybrid treatment model spanning non-invasive devices (oral appliances, EPAP, positional aids) and clinical surgical procedures (laser, radiofrequency, palatal stiffening).
2. Dual end-use settings: home care/self-care devices (especially oral appliances, EPAP) and surgical/clinic settings for procedures.
3. Regulatory/clinical complexity: Although devices may fall under moderate regulatory pathways, surgical interventions require specialist clinics, ENT or sleep-medicine specialists, IS/OR infrastructure, and often involve post-operative monitoring.
4. Growing shift towards minimally invasive solutions to improve patient acceptance, compliance and cost-effectiveness.
5. Geographic asymmetry: High awareness, reimbursement and infrastructure in North America/Europe; emerging growth in Asia Pacific/Latin America with rising diagnosis rates, but often lower reimbursement and device penetration.

Device Type Insights

The Anti-Snoring Devices and Snoring Surgery Market is segmented by device type into oral appliances, nasal devices, chin straps, tongue-stabilizing devices, and others. Oral appliances hold a major share as they are non-invasive and highly effective in repositioning the jaw to prevent airway obstruction during sleep. Nasal devices are gaining traction for their ease of use and affordability. Increasing awareness about sleep apnea and the growing demand for home-based, comfortable anti-snoring solutions are fueling the adoption of these devices globally.

Surgical Procedure Insights

Based on surgical procedure, the market includes uvulopalatopharyngoplasty (UPPP), radiofrequency ablation (RFA), tonsillectomy, pillar procedure, and others. UPPP remains a dominant segment due to its effectiveness in severe snoring and obstructive sleep apnea cases. Radiofrequency ablation is witnessing rapid adoption for its minimally invasive nature and quicker recovery time. The availability of advanced techniques, coupled with rising clinical success rates and patient preference for durable outcomes, drives the surgical segment’s steady market expansion.

Regional Insights

North America Anti-Snoring Devices and Snoring Surgery Market Trends

North America holds the largest share in the global market, owing to high prevalence of snoring and sleep-disordered breathing, strong awareness of associated health risks, well-established sleep-medicine infrastructure, and advanced adoption of both device-based interventions and surgical procedures. According to Vantage Market Research, North America is currently the largest region. High disposable incomes, reimbursement frameworks, large pool of sleep clinics/ENT specialists and strong dental/sleep appliance industry drive market uptake. The U.S. in particular has significant demand for non-CPAP alternatives (oral appliances) and minimally invasive surgeries, accelerating growth in both device and surgical segments.

Europe Market Anti-Snoring Devices and Snoring Surgery Trends

Europe exhibits steady growth in the anti-snoring devices and surgery market, supported by growing public awareness around sleep health, strong healthcare infrastructure, and increasing availability of minimally invasive ENT procedures. However, adoption is somewhat moderated by varied reimbursement structures across countries, higher procedural costs, and differences in home-device penetration. Key Western European countries (Germany, U.K., France) show strong activity in sleep medicine, dental-sleep clinic collaborations, and device innovation. As consumer focus on wellness and good sleep quality increases, device uptake in Europe is expected to accelerate.

Asia Pacific Anti-Snoring Devices and Snoring Surgery Market Trends

The Asia Pacific region is forecast to be the fastest-growing region for the anti-snoring devices and surgery market. Vantage Market Research identifies Asia Pacific as the fastest region. Rapid urbanisation, rising obesity and geriatric populations, increasing disposable incomes, expanding healthcare infrastructure and improving diagnosis of sleep disorders are major growth catalysts. Devices (oral appliances, positional aids) are gaining traction in countries such as India, China, Japan and Southeast Asia. Minimally invasive surgical procedures are also being introduced to expand treatment access in emerging markets. The low baseline adoption in many countries offers significant room for growth.

Latin America Anti-Snoring Devices and Snoring Surgery Market Trends

In Latin America, the market is developing with moderate growth projected. A rising awareness of snoring, increasing access to healthcare services, and growing private-sector investment are driving uptake of both devices and surgical treatments. However, challenges include limited reimbursement, lower per-capita sleep-medicine infrastructure and consumer awareness deficits. Nevertheless, as device costs decline and home use becomes more common, Latin America is expected to gain share in the global market over the forecast period.

Middle East & Africa Anti-Snoring Devices and Snoring Surgery Market Trends

The Middle East & Africa region is currently less mature in terms of anti-snoring device and treatment adoption but presents an emerging opportunity. Healthcare infrastructure upgrades in Gulf Cooperation Council (GCC) countries, growing wellness and sleep health awareness, and rising ENT/surgical capabilities are enhancing market prospects. However, structural barriers such as lower diagnosis rates, limited access to specialist care, and weak reimbursement frameworks hinder growth. As these barriers are addressed, growth in this region may accelerate.

Top Key Players Anti-Snoring Devices and Snoring Surgery Market

1. Endo Pharmaceuticals Inc.
2. KARL STORZ SE & Co. KG
3. Lumenis
4. Olympus Winter & IBE GMBH
5. Urologix LLC
6. Boston Scientific Corporation
7. LISA Laser USA
8. ProArc Medical
9. Urovision-Urotech
10. Teleflex Incorporated.
11. Richard Wolf GmbH.
12. BD
13. Biolitec AG

These companies are actively involved in expanding portfolios of anti-snoring devices (oral appliances, positional aids) and minimally invasive surgical platforms (laser, RF). Strategic focus includes technological innovation (smart, connected devices), geographic expansion (especially into Asia Pacific and Latin America), and partnerships or distribution alliances to boost home-use adoption and clinic-based interventions.

Recent Developments

1. In January 2024, DeRUCCI Group launched the AI Series T11 Pro Smart Mattress, a sleep-health product line that includes an anti-snoring pillow incorporating AI sensors and smart positional adjustment aimed at reducing snoring by up to 89%.
2. In May 2025, the anti-snoring devices market (exclusive of surgery) was valued at USD 1.42 billion in 2024 and projected to reach USD 2.28 billion by 2030 (CAGR ~8.21%), highlighting rising home-based device usage, smart connectivity and growing wellness orientation.

Market Scope

The Anti-Snoring Devices and Snoring Surgery Market Report by Vantage Market Research provides a comprehensive analysis of global market performance, covering revenue growth, forecast trends, and innovations from 2024 to 2035. The report examines market segmentation by Device Type (Oral Appliances, Nasal Devices, Chin Straps, etc.) and Surgical Procedure (UPPP, RFA, Tonsillectomy, etc.), alongside key regional insights and competitive landscape. It further highlights emerging technologies, patient adoption trends, and strategic initiatives shaping the future of sleep disorder treatment worldwide.

Market Dynamics

Driver:

The primary driver of market growth is the rising prevalence of snoring and sleep-disordered breathing (SDB)/obstructive sleep apnea (OSA) driven by global increases in obesity, ageing populations, alcohol and tobacco use, and sedentary lifestyles. Many adults habitually snore and are at risk of OSA; the growing recognition among clinicians and consumers of the health risks associated with untreated snoring and SDB (including cardiovascular disease, daytime fatigue, cognitive impairment) is forcing action. This surge in demand is fueling uptake of both devices and surgical solutions.

Restraint:

A significant restraint is patient compliance and adoption rates, particularly for device-based therapies, and the costs and access limitations for surgical treatments. Oral appliances and EPAP devices can be uncomfortable or have adherence issues; surgeries may be expensive, less reimbursed in some markets, and require specialist infrastructure. Moreover, many patients and clinicians still perceive snoring as a nuisance rather than a medical problem, leading to under-treatment.

Opportunity:

Major opportunities exist in home-care and consumer-oriented device segments, emerging markets (Asia Pacific, Latin America, Middle East & Africa) where baseline penetration is still low, and minimally invasive surgical technologies for outpatient or clinic-based settings. Smart connected devices, wearables, integration with sleep apps and tele-monitoring provide growth avenues. Moreover, growing alliances between dental clinics, sleep-medicine centres and device makers open alternative pathways for treatment.

Challenges:

Challenges include regulatory and reimbursement variability across regions, fragmented treatment pathways (sleep clinics, dental, ENT, home care), competition from CPAP therapy (especially for OSA), and the need for evidence of long-term outcomes and cost-effectiveness for newer devices and surgical procedures. Furthermore, reducing cost, increasing comfort/adherence and raising awareness among patients and providers remain substantial hurdles.

Market Segmentation

1. By Device Type: Oral Appliances; Nasal Devices; Chin Straps; Tongue-Stabilizing Devices; EPAP Therapy Devices; Position Control Devices.
2. By Surgical Procedure: Laser-Assisted Uvulopalatoplasty (LAUP); Radiofrequency Ablation (RFA); Pillar Procedure; Uvulopalatopharyngoplasty (UPPP); Injection Snoreplasty; Palatal Stiffening; Other Surgical Procedures.
3. By Region: North America; Europe; Asia Pacific; Latin America; Middle East & Africa.

Frequently Asked Questions

1. What was the size of the global anti-snoring devices and snoring surgery market in 2024?

USD 0.91 billion.

1. What is the projected market size by 2035?

USD 2.58 billion.

1. What is the CAGR from 2025 to 2035?

9.95%.

1. Which region currently dominates the market?

North America currently holds the largest share.

1. Which surgical procedure segment is leading?

Radiofrequency Ablation (RFA) is expected to lead due to minimal side-effects and recovery time.

1. Which device type segment dominates?

Oral appliances dominate the device segment owing to their ease of use and patient preference.

1. What are the main growth opportunities?

Opportunities lie in home-use smart devices, minimally invasive outpatient surgeries, and emerging regions such as Asia Pacific and Latin America.

1. What are key challenges faced by the market?

Key challenges include treatment compliance, cost/access for surgery, perception of snoring as a non-medical issue, reimbursement and regulatory hurdles.